- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of pneumococcal disease
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 780KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 192KB)
Pneumococcal conjugate vaccine, 20-valent – November 2023
Pneumococcal Conjugate Vaccine, 20-Valent : 0.5 mL pre-filled syringe; Prevenar 20®
Last updated
1 March 2024